Product Details

Levofloxacin + Ornidazole Tablets BP 1000 mg deliver a high-quality combination therapy that meets British Pharmacopoeia (BP) standards. This fixed-dose combination manages mixed aerobic and anaerobic bacterial infections, combining broad-spectrum antibacterial and antiprotozoal action in a single tablet.

The tablets combine:

• Levofloxacin, a fluoroquinolone antibiotic that eliminates a broad range of aerobic bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV, and
• Ornidazole, a nitroimidazole antiprotozoal and antibacterial agent that targets anaerobic bacteria and protozoa by disrupting their DNA structure.

Doctors commonly prescribe this combination for mixed infections of the gastrointestinal tract, respiratory tract, and skin/soft tissue, as well as for surgical prophylaxis where both aerobic and anaerobic coverage is needed. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable therapeutic results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP-standard compliant combination therapy
• Treats mixed aerobic and anaerobic bacterial infections
• Delivers combined antibacterial and antiprotozoal action
• Accurate 1000 mg dosage per tablet
• Maintains a high-purity, stable formulation
• Uses hygienic blister packaging for safe storage
• Suits hospital, clinical, and pharmacy use